You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
BMC Cancer, March 2015
Thomas Brodowicz, Bernadette Liegl-Atzwager, Emmanuelle Tresch, Sophie Taieb, Andrew Kramar, Viktor Gruenwald, Marie Vanseymortier, Stéphanie Clisant, Jean-Yves Blay, Axel Le Cesne, Nicolas Penel
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||6||13%|
|Student > Bachelor||4||8%|
|Student > Ph. D. Student||4||8%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||17||35%|
|Biochemistry, Genetics and Molecular Biology||4||8%|
|Agricultural and Biological Sciences||3||6%|
|Pharmacology, Toxicology and Pharmaceutical Science||2||4%|